These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 1426662

  • 1. Recent progress in immunopharmacology and therapeutic effects of polysaccharides.
    Chihara G.
    Dev Biol Stand; 1992; 77():191-7. PubMed ID: 1426662
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Preclinical evaluation of lentinan in animal models.
    Chihara G.
    Adv Exp Med Biol; 1983; 166():189-97. PubMed ID: 6606302
    [Abstract] [Full Text] [Related]

  • 8. [Effect of lentinan administration of adrenalectomized rats and patients with breast cancer].
    Kosaka A, Wani T, Hattori Y, Yamashita A.
    Gan To Kagaku Ryoho; 1982 Aug; 9(8):1474-81. PubMed ID: 6764117
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Modulation of the anti-tumor effect of BRM under various nutritional or endocrine conditions].
    Akimoto M, Nishihira T, Kasai M.
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1270-6. PubMed ID: 3729450
    [Abstract] [Full Text] [Related]

  • 12. [Results of phase III study of lentinan].
    Taguchi T, Furue H, Kimura T, Kondo T, Hattori T, Itoh I, Ogawa N.
    Gan To Kagaku Ryoho; 1985 Feb; 12(2):366-78. PubMed ID: 3918510
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Current status and perspectives of immunomodulators of microbial origin.
    Chihara G, Maeda YY, Hamuro J.
    Int J Tissue React; 1982 Feb; 4(3):207-25. PubMed ID: 6815071
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Anti-cancer effects of BRMs associated with nutrition in cancer patients].
    Nishihira T, Akimoto M, Mori S.
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-3):1615-20. PubMed ID: 3382233
    [Abstract] [Full Text] [Related]

  • 17. [A case report of advanced gastric cancer remarkably responding to mitomycin C, aclacinomycin A, SF-SP and lentinan combination therapy].
    Maekawa S, Saku M, Kinugasa T, Yoshida Y, Ikejiri K, Yakabe S.
    Gan To Kagaku Ryoho; 1990 Jan; 17(1):137-40. PubMed ID: 2105085
    [Abstract] [Full Text] [Related]

  • 18. Monoclonal antibody-dependent murine macrophage-mediated cytotoxicity against human tumors is stimulated by lentinan.
    Herlyn D, Kaneko Y, Powe J, Aoki T, Koprowski H.
    Jpn J Cancer Res; 1985 Jan; 76(1):37-42. PubMed ID: 3918909
    [Abstract] [Full Text] [Related]

  • 19. Clinical efficacy of lentinan on patients with stomach cancer: end point results of a four-year follow-up survey.
    Taguchi T.
    Cancer Detect Prev Suppl; 1987 Jan; 1():333-49. PubMed ID: 3121179
    [Abstract] [Full Text] [Related]

  • 20. Denaturation and renaturation of a beta-1,6;1,3-glucan, lentinan, associated with expression of T-cell-mediated responses.
    Maeda YY, Watanabe ST, Chihara C, Rokutanda M.
    Cancer Res; 1988 Feb 01; 48(3):671-5. PubMed ID: 2446749
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.